Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from the platform after accusing the company of selling “illegitimate, knockoff ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

The company initially plans to launch the generic version in Canada, India, Brazil, Turkey and other emerging markets, ...

So Wegovy’s approval by the FDA may open up a whole new avenue of possible approaches to managing obesity and overweight conditions. Other GLP-1-like treatments are already under development.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Health Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure ...

Wegovy’s Popularity Is Now Sparking A Debate On The Causes Of Obesity The internet had * thoughts * after a 60 Minutes segment said genetics is to blame. By Amelia Harnish Published: Jan 27 ...

Wegovy is about to go mainstream. A wild idea recently circulated about the future of aviation: If passengers lose weight via obesity drugs, airlines could potentially cut down on fuel costs.

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Wegovy is part of a new class of injectable medications for obesity. On Wednesday, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound, a version of the diabetes drug Mounjaro ...